Prosight Management as of Sept. 30, 2020
Portfolio Holdings for Prosight Management
Prosight Management holds 47 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alexion Pharmaceuticals | 6.3 | $13M | 116k | 114.43 | |
| Arena Pharmaceuticals Com New | 5.8 | $12M | 163k | 74.79 | |
| Bristol Myers Squibb (BMY) | 5.3 | $11M | 186k | 60.29 | |
| Reata Pharmaceuticals Cl A | 5.3 | $11M | 115k | 97.42 | |
| Cue Biopharma (CUE) | 5.1 | $11M | 710k | 15.05 | |
| Baxter International (BAX) | 4.7 | $9.8M | 122k | 80.42 | |
| Change Healthcare | 4.3 | $9.1M | 624k | 14.51 | |
| Aurinia Pharmaceuticals (AUPH) | 4.2 | $8.8M | 595k | 14.73 | |
| Aldeyra Therapeutics (ALDX) | 3.8 | $8.1M | 1.1M | 7.41 | |
| Cigna Corp (CI) | 3.8 | $8.0M | 47k | 169.40 | |
| Encompass Health Corp (EHC) | 3.3 | $7.0M | 108k | 64.98 | |
| Centene Corporation (CNC) | 3.3 | $6.9M | 118k | 58.33 | |
| Aptose Biosciences Com New | 3.3 | $6.8M | 1.1M | 6.00 | |
| Zimmer Holdings (ZBH) | 3.1 | $6.6M | 49k | 136.13 | |
| Uniqure Nv SHS (QURE) | 3.0 | $6.3M | 171k | 36.83 | |
| Prothena Corp SHS (PRTA) | 2.6 | $5.4M | 545k | 9.99 | |
| Metacrine Ord | 2.5 | $5.3M | 519k | 10.21 | |
| Meiragtx Holdings (MGTX) | 2.5 | $5.2M | 391k | 13.24 | |
| Ac Immune Sa SHS (ACIU) | 2.1 | $4.5M | 923k | 4.88 | |
| Albireo Pharma | 1.9 | $4.1M | 123k | 33.37 | |
| Iovance Biotherapeutics (IOVA) | 1.9 | $4.0M | 121k | 32.92 | |
| Alexion Pharmaceuticals Call Call Option | 1.9 | $3.9M | 34k | 114.44 | |
| Translate Bio | 1.8 | $3.8M | 282k | 13.61 | |
| Ishares Tr Put Put Option | 1.7 | $3.6M | 24k | 149.79 | |
| Cellectis S A Spon Ads (CLLS) | 1.6 | $3.4M | 185k | 18.50 | |
| Kura Oncology (KURA) | 1.6 | $3.3M | 107k | 30.64 | |
| Zogenix Com New | 1.5 | $3.2M | 181k | 17.92 | |
| Organogenesis Hldgs (ORGO) | 1.2 | $2.6M | 677k | 3.84 | |
| Cara Therapeutics | 1.1 | $2.2M | 175k | 12.72 | |
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.9 | $2.0M | 513k | 3.88 | |
| 1life Healthcare | 0.9 | $1.9M | 66k | 28.35 | |
| Kezar Life Sciences | 0.8 | $1.8M | 366k | 4.84 | |
| Magenta Therapeutics | 0.8 | $1.7M | 244k | 6.80 | |
| Quidel Corporation | 0.8 | $1.6M | 7.5k | 219.33 | |
| Establishment Labs Holdings Ord (ESTA) | 0.8 | $1.6M | 86k | 18.53 | |
| Catalyst Biosciences Com New | 0.6 | $1.3M | 302k | 4.30 | |
| Bioxcel Therapeutics | 0.6 | $1.3M | 30k | 43.36 | |
| Adma Biologics (ADMA) | 0.6 | $1.3M | 535k | 2.39 | |
| Karuna Therapeutics Ord | 0.6 | $1.2M | 16k | 77.34 | |
| Immatics SHS (IMTX) | 0.6 | $1.2M | 114k | 10.61 | |
| Neoleukin Therapeutics | 0.4 | $797k | 66k | 12.01 | |
| Evofem Biosciences | 0.3 | $590k | 250k | 2.36 | |
| Apollo Endosurgery | 0.2 | $469k | 278k | 1.69 | |
| Orthopediatrics Corp. (KIDS) | 0.2 | $386k | 8.4k | 45.96 | |
| Stealth Biotherapeutics Corp Sponsored Ads | 0.2 | $346k | 256k | 1.35 | |
| Biotelemetry | 0.1 | $274k | 6.0k | 45.67 | |
| Reata Pharmaceuticals Call Call Option | 0.1 | $156k | 1.6k | 97.50 |
